MEDI0639 - AstraZeneca
AstraZeneca: Q4 & FY 2015 Results (AstraZeneca) - Feb 5, 2016 - Anticipated top-line data from P1 trial (NCT01577745) in adults with advanced solid tumors including SCLC in H2 2016  
Anticipated P1 data • Oncology • Small Cell Lung Cancer
https://www.astrazeneca.com/our-company/investor-relations.html
 
Feb 5, 2016
 
.
 
a3ce3782-d55e-46f2-a0a3-47642d182797.jpg